CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Ambulatory Inotrope Infusions in Advanced Heart Failure - A Systematic Review and Meta-Analysis The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction Risk of Mortality Following Catheter Ablation of Atrial Fibrillation The year in cardiovascular medicine 2020: heart failure and cardiomyopathies From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

Original Research2020 Jul 18.

JOURNAL:ESC Heart Fail. Article Link

Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF study

JA Borovac, D Glavas, ZS Grabovac et al. Keywords: acute decompensated heart failure; catestatin; HF; hospital mortality; risk stratification; soluble suppression of tumourigenicity

Full Text PDF